These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10492510)

  • 1. Raynaud's syndrome in a patient treated with milnacipran.
    Bourgade B; Jonville-Béra AP; Le Garé C; Ferquel D; Autret-Leca E
    Ann Pharmacother; 1999 Sep; 33(9):1009-10. PubMed ID: 10492510
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine.
    Yoshida K; Higuchi H; Ozaki N
    Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181
    [No Abstract]   [Full Text] [Related]  

  • 3. Levomilnacipran (Fetzima) a new SNRI for depression.
    Med Lett Drugs Ther; 2013 Dec; 55(1432):101-2. PubMed ID: 24419243
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 5. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milnacipran for fibromyalgia.
    Dempsey J
    Issues Emerg Health Technol; 2008 Feb; (114):1-4. PubMed ID: 18354855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran].
    Koshiishi T; Okuyama K
    Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran.
    Arai M
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):137-8. PubMed ID: 12486290
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
    Bernstein CD; Albrecht KL; Marcus DA
    Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of milnacipran and paroxetine in outpatients with major depression.
    Sechter D; Vandel P; Weiller E; Pezous N; Cabanac F; Tournoux A;
    J Affect Disord; 2004 Dec; 83(2-3):233-6. PubMed ID: 15555719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
    Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N
    Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.
    Steen A; Den Boer JA
    Int Clin Psychopharmacol; 1997 Sep; 12(5):269-81. PubMed ID: 9466161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible interaction between milnacipran and warfarin potassium.
    Sawamura J; Kozaki K; Mochizuki S; Ishigooka J
    J Clin Pharmacol; 2012 May; 52(5):780-1. PubMed ID: 22539653
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
    Kanetani K; Kimura M; Endo S
    J Nippon Med Sch; 2003 Aug; 70(4):313-20. PubMed ID: 12928711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milnacipran for chronic pain in the orofacial region.
    Pae CU
    Clin Neuropharmacol; 2010; 33(5):270. PubMed ID: 20864840
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse effects of antidepressants and antimanics].
    Tanaka T; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):362-5. PubMed ID: 12877003
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S; Arita S
    Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.